Assembly Biosciences, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Assembly Biosciences is a biotechnology company focused on developing new small-molecule antiviral therapies aimed at altering the progression of serious viral diseases. Its work targets infections that can have chronic or severe health impacts, including herpesviruses and infections caused by hepatitis B and hepatitis D viruses. Headquartered in South San Francisco, California, the company operates in the biotechnology research sector with a focus on virologic drug development. A key program, ABI-6250, is an oral entry inhibitor for chronic hepatitis D virus infection, and in May 2026 the company announced plans to broaden its development into cholestatic liver diseases, such as primary biliary cholangitis and primary sclerosing cholangitis. The expansion aligns with the company's focus on antiviral therapies for viruses that can drive long-term health challenges.